亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial

医学 超重 体质指数 随机对照试验 不利影响 腰围 肥胖 安慰剂 物理疗法 临床终点 临床试验 儿科 心理干预 减肥 内科学 体重管理 意向治疗分析 生活质量(医疗保健) 质量指数
作者
Aaron S. Kelly,Karthik Chandrasekhar Pamidipati,Marianna Rachmiel,Gitanjali Srivastava,Daniel S. Hsia,Claudia K. Fox,Erika Fortes,Lisa McLeod,Madhumita Murphy,Apurva Prakash
出处
期刊:JAMA [American Medical Association]
标识
DOI:10.1001/jama.2026.23420
摘要

Importance Information on the effects of tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist approved for obesity management in adults with obesity, remains limited in adolescents. Objective To evaluate the efficacy and safety of once-weekly tirzepatide in adolescents with obesity or overweight with at least 1 obesity-related complication. Design, Setting, and Participants This phase 3, randomized, double-blind, 72-week clinical trial was conducted at 31 medical research centers and hospitals in Canada, the Czech Republic, Israel, Italy, Poland, and the US from October 16, 2023, to June 2, 2026, among adolescents aged 12 years to younger than 18 years with obesity or overweight with at least 1 obesity-related complication. Interventions Participants were randomized 2:1 to receive once-weekly subcutaneous tirzepatide, escalated to a maximum tolerated dose (5, 10, or 15 mg), or placebo for 72 weeks, in addition to healthy lifestyle intervention. Main Outcomes and Measures The primary end point was percent change in body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) from baseline to week 72. Key secondary end points included percentages of participants achieving BMI reductions of at least 5%, at least 10%, at least 15%, and at least 20%; changes in BMI SD score; BMI expressed as a percentage of the 95th percentile; and body weight, waist circumference, and physical functioning from baseline to week 72. Safety outcomes included treatment-emergent adverse events, serious adverse events, and discontinuations due to adverse events. Results A total of 160 participants were randomized to receive tirzepatide (n = 109) or placebo (n = 51). Mean (SD) age at baseline was 14.6 (1.6) years, 99 participants (61.9%) were female, mean body weight was 109.7 kg, and mean BMI was 38.6. At week 72, tirzepatide was associated with 18.5% reduction in BMI, compared with 0.5% increase in BMI with placebo, demonstrating superiority over placebo (estimated treatment difference, −19.0 [95% CI, −23.9 to −14.1] percentage points; P < .001). Of 10 key secondary outcomes, all demonstrated statistically significant differences favoring tirzepatide compared with placebo. Overall, 79.6% of tirzepatide-treated participants achieved BMI reduction of at least 5% compared with 28.5% of participants in the placebo group (risk difference, 51.2 [95% CI, 36.3-66.1] percentage points; P < .001). The most common adverse events with tirzepatide treatment were gastrointestinal (mostly mild to moderate). Conclusions and Relevance In adolescents with obesity or overweight with obesity-related complications, tirzepatide, in addition to healthy lifestyle intervention, led to significant reductions in percent change in BMI compared with placebo at 72 weeks. Trial Registration ClinicalTrials.gov Identifier: NCT06075667
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
勤奋海白完成签到,获得积分10
6秒前
h11的应助被moiaoh采纳,获得100
7秒前
11秒前
sikhwan_发布了新的文献求助10
18秒前
38秒前
43秒前
44秒前
46秒前
47秒前
难过的白猫完成签到,获得积分10
49秒前
49秒前
50秒前
着急的靖柔完成签到,获得积分10
51秒前
53秒前
LeoYiS214完成签到,获得积分10
54秒前
55秒前
58秒前
1分钟前
1分钟前
小草没完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
heyecao22发布了新的文献求助20
1分钟前
老实映菱完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158751
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719285
捐赠科研通 7748357
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551971
邀请新用户注册赠送积分活动 2471339